CD79A and chronic obstructive pulmonary disease: The dose response relationship between IgA and exacerbation burden is further supportive of the hypothesis that immune function may play a role in defining exacerbation risk in individuals with COPD and highlights that there could also be a spectrum of increasing risk related to progressively lower IgA levels.